24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publication dates

All regions

Cancer Industry, March 2015 Market Reports from Top Publishers

You might be interested in: medical equipment, therapeutics, drug, cancer drug, melanoma, breast cancer, hospital, colorectal cancer, medical center, prostate cancer, leukemia, pancreatic cancer, blood banking, lymphoma, oncology.


 
1-10 of about 2 000 reports for Cancer

Medical Marijuana - From Illicit to Legal and Beyond to Pharmaceuticals - Global Markets, Competitors and Opportunities : 2015 - 2020 Analysis and Forecasts

Medical Marijuana - From Illicit to Legal and Beyond to Pharmaceuticals - Global Markets, Competitors and Opportunities : 2015 - 2020 Analysis and Forecasts

  • $ 1 950
  • Industry report
  • February 2015
  • by Amadee and Company

The objective of this report is to provide a detailed analysis of the global market for Medical Marijuana. It is also to provide a comprehensive analysis of the leading companies producing these products, ...

Cancer Drug News 23 FEBRUARY 2015

Cancer Drug News 23 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • February 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - New ACA Initiative To Be Tested To Manage Rising Cancer Costs And Improve Cancer Care Industry Brief - Eagle Licenses Teva To Commercialise Bendamustine Rapid Infusion In US Industry ...

Therapeutics for ”Silent” Cancers

Therapeutics for ”Silent” Cancers

  • $ 6 650
  • Industry report
  • February 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for “silent” cancers was valued at $8.5 billion in 2013 and $9 billion in 2014. This market is expected to reach almost $13.6 billion by 2019, with a compound annual ...

Cancer Drug News 16 FEBRUARY 2015

Cancer Drug News 16 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • February 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - Novartis Under Pressure To Maximise Revenue Growth Of GSK's Oncology Portfolio Industry Brief - Kinex Licenses BCRP-Targeted Patents From Hong Kong Polytechnic University/McGill ...

Hematological Malignancies: Multiple Myeloma (MM) - Early and Robust Diagnosis along with New Treatment Options can have Considerable Impact on Management of the Disease

Hematological Malignancies: Multiple Myeloma (MM) - Early and Robust Diagnosis along with New Treatment Options can have Considerable Impact on Management of the Disease

  • $ 3 000
  • Industry report
  • February 2015
  • by MP Advisors

While targeting unmet needs in the treatment of hematological malignancies/ cancer through innovative drug development strategies have witnessed favorable outcomes, the specific choice of the therapies ...

2015 Current and Emerging Suppliers Of Immunodiagnostic, Microbiology, Cancer Diagnostic, Molecular Diagnostic, Hematology, Coagulation and Blood Banking Instruments and Reagents

2015 Current and Emerging Suppliers Of Immunodiagnostic, Microbiology, Cancer Diagnostic, Molecular Diagnostic, Hematology, Coagulation and Blood Banking Instruments and Reagents

  • $ 8 500
  • Industry report
  • February 2015
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides analyses of current and emerging suppliers of immunodiagnositc, microbiology, cancer diagnostic, molecular diagnostic, hematology, coagulation and blood ...

2015 Assessments of Leading Cancer Diagnostic Market Players--Strategic Analyses of Major Suppliers and Emerging Market Entrants

2015 Assessments of Leading Cancer Diagnostic Market Players--Strategic Analyses of Major Suppliers and Emerging Market Entrants

  • $ 2 500
  • Industry report
  • February 2015
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current ...

Key Pharma News 16 FEBRUARY 2015

Key Pharma News 16 FEBRUARY 2015

  • $ 1 415
  • Industry report
  • February 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - New Compounds Fill Pipelines As R&D Expenditure Rises Industry Trend Analysis - Genzyme/Voyager Deal Demonstrates Gene Therapy's Revival Industry Trend Analysis - Hospira Eyes ...

Pakistan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Pakistan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2015
  • by Business Monitor International

BMI View: Despite the fact a significant number of multinationals are present in Pakistan, and the country's significant industry potential, the leading international companies play a minimal role in ...

Cancer Drug News 09 FEBRUARY 2015

Cancer Drug News 09 FEBRUARY 2015

  • $ 1 114
  • Industry report
  • February 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - New Compounds Fill Pipelines As R&D Expenditure Rises Industry Trend Analysis - Pfizer's Approval In BC Set To Give Positive Stroke To Company's Declining Revenues Industry Brief ...

About 20 000 reports for Cancer

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • January 2013
    64 pages
  • Cancer  

  • United States  

    North America  

View report >

About 100 Companies for Cancer

Read our Company Profiles

Novartis Inc.

Switzerland

GlaxoSmithKline P.L.C.

United States

Eli Lilly and Co.

United States

GlaxoSmithKline PLC

United Kingdom

AstraZeneca PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.